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ﬂow changes during negative ﬂuid balance ultraﬁltration in patients with oliguric AKI.
Materials and methods: Patients with oliguric AKI on renal replacement therapy were included after
hemodynamic stabilization. Targetwas a predeﬁned negative ﬂuid balance; subsequently, a stepwise decrease
in amount of substitution ﬂuid was achieved. The data were recorded at baseline and after each change.
Results: Fifteen patients were included in the study. Microcirculatory blood ﬂow index did not change
signiﬁcantly between baseline and endpoint (2.90 [2.87-3.00] vs 2.90 [2.75-3.00], P= .57). During treatment,
heart rate decreased from 96 (80-111) to 94 (79-110) beats per minute (P = .01), without a signiﬁcant
change in mean arterial blood pressure (80 [68-95 mm Hg] vs 79 [65-91 mm Hg], P = .5).
Conclusion:Microcirculatory bloodﬂow is not altered by reduced substitutionduring renal replacement therapy.
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Acute kidney injury (AKI) is a recognized complication in patients
admitted to the intensive care unit (ICU); 6% of ICU patients will develop
oliguric kidney failure. Themortality rate increasesup to60% in this group,
with an increased risk for chronic kidney disease [1,2]. Oliguric AKI poses
several challenges to the ICU physician. Although still subject to debate,
there seems to be consensus to some extent about the initial timing, dose,
and type of renal replacement therapy (RRT) in the acute phase of AKI.
However, little is knownabout the timingand theultraﬁltrationdose after
the initial sepsis resuscitation [3–5].
This observation is noteworthy because optimal ﬂuid management
appears to be relevant. Although ﬂuid therapy remains an important
cornerstone in sepsis treatment,ﬂuidoverload is clearly an independent
risk factor for morbidity and mortality. More importantly, an indepen-
dent association exists between negative ﬂuid balance and decreased
90-day mortality [6–11]. However, in the clinical setting, assessing the
balance between the ongoing need for ﬂuid therapy and ﬂuid overload
is difﬁcult. Practical guidelines concerning when and how to reduce
positive ﬂuid balances seem to be lacking. In the last decade, in vivomicroscopy of microcirculatory blood ﬂow has been suggested to be an
alternative modality for assessing volume status. In an animal model of
hemorrhagic shock, the microcirculatory blood ﬂow tracked progres-
sive blood loss, whereas the heart rate and blood pressure changes
occurred only in the late phase of shock [12]. In the human setting of
ﬂuid resuscitation, both passive leg raising and intravascular volume
expansion were associated with increased microcirculatory blood ﬂow
during septic shock [13]. In the setting of chronic renal failure, rapid
changes in volume status during hemodialysis with ultraﬁltration were
detected by signiﬁcant changes in microcirculatory blood ﬂow;
however, these rapid volume status changes were not sensed by
standard macrohemodynamic variables [14]. Pranskunas et al [15] not
only linked improvedmicrovascular bloodﬂow toﬂuid therapy but also
established its relationship with attenuated clinical signs of impaired
organ perfusion. These studies contribute to the understanding that
intravascular hypovolemia can reﬂect microcirculatory blood ﬂow
changes, which are not sensed by conventional methods, and that the
technique can track rapid changes [16].
The aim of the present study was to assess potential changes in
microcirculatory blood ﬂow during the beginning of negative ﬂuid
balance ultraﬁltration after the initial stabilization of shock patients
with oliguric AKI. We hypothesized that mild negative ﬂuid balance in
this patient group is not associated with impaired microcirculatory
blood ﬂow.
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Fig. 1. Protocol.
Table 1
Baseline characteristics
N = 14
Age, y 76 (69-79)
Sex, male/female, n 11/3
Reason for ICU admittance, n (%)
Sepsis 8 (57%)
Cardiogenic shock after cardiac surgery 4 (29%)
Other 2 (14%)
APACHE II 26 (20-29)
APACHE IV 93 (46-107)
SOFA 12 (10-13)
Hospital mortality (%) 25%
Mechanical ventilation, n (%) 14 (100%)
Number of patients on vasopressors, n (%) 6 (43%)
Number of patients on inotropics, n (%) 1 (7%)
Creatinine before admittance, mmol/L 86 (76-135)
Diuresis at start protocol, hourly, mL 0.0 (0.0-11.25)
Creatinine at start protocol, mmol/L 125 (71-173)
Urea at start protocol, mmol/L 9.1 (8.0-13.8)
Length of stay ICU, d 15 (10-28)
Length of stay hospital, d 26 (14-32)
ICU-treatment before inclusion, d 5 (3-7)
RRT, d 7 (6-12)
Developed chronic kidney failure, n (%) 2 (14%)
SOFA: Sequential Organ Failure Assessment.
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2.1. Patients
This single-center, prospective, observational study was approved
by the medical ethics committee (Medical Centre Leeuwarden, the
Netherlands) and registered with ClinicalTrials.gov number
NTC 01362088.
The patients with oliguric kidney failure who were treated with
RRT after hemodynamic stabilization were eligible for the study.
Hemodynamic stabilizationwas deﬁned as the absence of the need for
ﬂuid therapy or positive ﬂuid balance, a mean arterial blood pressure
greater than 60 mm Hg, a central/mixed venous oxygen saturation
greater than 65%, normal lactate levels, and stable or decreased
inotropic dosage.
The inclusion criteria were patients older than 18 years, informed
consent, and a clinical status indicative of negative ﬂuid balance. The
exclusion criteria included the inability to obtain sidestream dark ﬁeld
(SDF) images, such as maxillofacial surgery.
2.2. Protocol
Before the start of the protocol, the attending physician deter-
mined the need for and the amount of negative ﬂuid balance for the
next 12 hours. Subsequently, a stepwise decrease in the amount of
substitution was achieved (Fig. 1). Each step lasted 1 hour. Sidestream
dark ﬁeld imaging of the sublingual area was obtained after each
substitution step. At the end of the protocol, the patient was placed in
the Trendelenburg position for several minutes, and simultaneous SDF
imaging was performed.
2.3. Renal replacement therapy
All of the patients were treated using continuous venovenous
hemoﬁltration (CVVH) (multiFiltrate, Fresenius Medical Care, Bad
Homburg, Germany), equipped with a Nipro UF-205 dialyzer (Nipro
Corporation, Osaka, Japan). During treatment, the blood ﬂow
was standardized at 200 mL/min using an ultraﬁltration ﬂow at
3000 mL/h. The total amount of postﬁlter buffered substitution
solution (SH 44 HEP or SH 53, Dirinco, Rosmalen, the Netherlands)
was adjusted according to the preset net ﬂuid balance. The regional
anticoagulation was achieved using trisodium citrate.
2.4. Microvascular imaging and analysis
Sidestream dark ﬁeld imaging, which is a stroboscopic light-
emitting diode, ring-based imaging modality, is incorporated in a
handheld device. Sidestream dark ﬁeld imaging has been validated for
clinically observing the microcirculation. If a wavelength within the
hemoglobin absorption spectrum (eg, 530 nm) is chosen, red blood
cells will appear dark. Sidestream dark ﬁeld images are obtained from
3 different regions of the sublingual microcirculation [17,18].
Clips were acquired and stored using a digital videotape (Video
Walkman GV-D 1000E, Sony, Tokyo, Japan). Subsequently, the images
were captured in 5- to 10-second representative AVI-format video
clips (SonyDVgate, Sony).
The images were randomly presented to prevent interimage
coupling. Ofﬂine analysis was performed using the AVA 3.0 software
package (MicroVision Medical, Amsterdam, the Netherlands) in
compliancewith the recommendations of a roundtable conference [19].
2.5. Data
The following data were recorded at baseline: general character-
istics and severity of illness according to Acute Physiology and Chronic
Health Evaluation (APACHE) IV and Sequential Organ FailureAssessment scores calculated over the ﬁrst 24 hours after ICU
admission. Macrohemodynamic variables, SDF images, central venous
oxygen saturation, and arterial blood gases were recorded at baseline
and after each substitution step.
Table 2
Fluid balances
N = 14
Cumulative ﬂuid balance prior to start protocol, L 8.5 (6.1 to 12.1)
Fluid balance 24 h prior to start protocol, L 0.4 (−0.2 to 1.0)
Targeted ﬂuid balance for the ﬁrst 12 h of protocol, L −0.5 (−0.5 to −0.5)
Achieved ﬂuid balance for the ﬁrst 12 h of protocol, L −0.9 (−1.2 to −0.2)
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index (MFI) between zero-balance ultraﬁltration and maximum
negative ﬂuid balance substitution rate. The secondary outcomes
included changes in blood pressure, heart rate,ΔT (difference between
skin temperature and core temperature), and total vessel density.
2.6. Statistics
Based on previous observations, we anticipated a mean MFI at
baseline of 3 with a standard deviation of 0.2 [20]. We calculated a
sample size of 14 patients to detect an absolute difference of 0.4 inMFI
in a single-sided test with a .05 type I error and an 80% probability.
SPSS (version 18/21; SPSS Inc, Chicago, IL) was used for statistical
analysis. The data are presented as the median and interquartile
range. Because of the small sample sizes, comparisons between
baseline and endpoint were restricted to nonparametric tests for
paired data (Wilcoxon test).
3. Results
3.1. Patients
In a 13-month period, 15 patients were included in the study. The
baseline characteristics are presented in Table 1. The protocol was
stopped prematurely in 1 patient because of hypotension and in 1
patient who could not endure the Trendelenburg position; both
patients are included in the data analysis. During the analysis, 1
patient was excluded because of poor image quality.
During the protocol, the median targeted ﬂuid balance was−0.5 l,
whereas the ﬂuid balance achievedwas−0.9 l (Table 2). Eleven (79%)
of 14 patients completed the protocol after 2 hours (maximum =
4 hours).
3.2. Primary outcome
The primary outcome of the study was the observed difference
between the microcirculatory blood ﬂow before and after targetFig. 2. Microcirculation ﬂow index duringreduction of substitution ﬂow with CVVH. The MFI did not change
signiﬁcantly between the baseline MFI value and the end point in the
small vessels (2.90 [2.87-3.00] vs 2.90 [2.75-3.00], respectively; P =
.57) (Fig. 2). After being placed in the Trendelenburg position, the
patients’ MFI values did not differ in small vessels (Table 3).3.3. Secondary outcome
During treatment, the heart rate decreased from 96 (80-111) to 94
(79-110) beats per minute (P = .01), without a signiﬁcant change in
mean arterial blood pressure (80 [68-95] vs 79 [65-91] mm Hg,
respectively; P = .5). Additionally, the central venous saturation was
69% (67%-77%) at baseline and did not change over time (70% [66%-
77%], P= .95). Interestingly, the PaO2/FIO2 ratio (P/F) improved during
the protocol (Table 3). The hematocrit and lactate levels remained
unchanged (Table 4).4. Discussion
The primary ﬁnding of this study was that we observed no change
in microcirculatory blood ﬂow, using sublingual in vivo microscopy,
during negative ﬂuid balance ultraﬁltration in stabilized ICU patients.
Moreover, macrohemodynamic variables, such as blood pressure,
heart rate, and central venous saturation (ScVO2), remained unal-
tered. These data suggest that, after stabilization of the primary shock
insult, a net negative ﬂuid balance may be achieved without reduced
organ perfusion or heart rate acceleration.
At ﬁrst glance, our result may not be consistent with the ﬁndings in
the recent literature. During progressive hemorrhage in an animal
model, the microcirculatory ﬂow alterations were consistent with the
amount of blood loss [12]. Others have observed that, in a lower body
negative pressure model of hypovolemia, there was a signiﬁcant
decrease in microvascular ﬂow and capillary density [21]. In stable
patients with chronic renal failure, ultraﬁltration was associated with
profound microcirculatory ﬂow alterations and could be instanta-
neously reversed in the Trendelenburg position [14]. Moreover, others
have demonstrated that swift changes in volume status during septic
shock were closely related to sublingual microcirculatory ﬂow
alterations [13,15].
In our study, a stepwise increase in ultraﬁltration with a net
negative ﬂuid balance was not accompanied bymicrovasculatory ﬂow
changes; this observation may have alternative explanations. Where-
as, in the previous literature, the different models were indicative of
substantial hypovolemia, our patientsmay have been hypervolemic at
the start of the study. Because ﬂuid resuscitation was combined withtarget reduction of substitution ﬂow.
Table 3
Macro- and microvascular variables
N = 14 Baseline T-end P
Heart rate, beats per minute 96 (80-111) 94 (79-110) .01⁎
Blood pressure syst., mm Hg 127 (103-145) 122 (97-145) .10
Blood pressure, dia., mm Hg 62 (50-71) 59 (49-64) .12
Blood pressure, mean, mm Hg 80 (68-95) 79 (65-91) .60
Norepinephrine, μg/(kg min) 0.08 (0.03-0.12) 0.08 (0.04-0.1) .32
ScVO2 % 69 (67-77) 70 (66-77) .95
Δ temperature, °C 4.4 (3.2-5.2) 4.4 (2.95-5.6) .35
P/F ratio 261 (205-359) 285 (207-370) .02⁎
CVP, mm Hg 13 (10-16) 11 (7-14) .05
MFI small vessels 2.90 (2.87-3.00) 2.90 (2.75-3.00) .57
MFI large vessels 3.00 (3.00-3.00) 2.96 (2.98-3.00) .27
TVD small vessels 18.44 (15.76-21.53) 19.46 (16.80-22.39) .08
De Backer, small vessels 12.26 (10.21-13.66) 12.92 (11.07-14.26) .10
PPV small vessels 0.98 (0.97-1.00) 0.98 (0.98-0.99) .50
PVD small vessels 18.10 (15.31-20.86) 19.08 (16.53-21.67) .14
Heterogeneity score (%) 8.7 (0.0-13.1) 0 (0.0-20.5)
ScVO2: central venous saturation; CVP: central venous pressure; TVD: total vessel
density; PPV: percentage perfused vessels; PVD: perfused vessel density.
⁎ P b .05.
Table 4
Laboratory results
N = 14 Baseline T-end P
Hemoglobin, mmol/L 5.7 (5.4-6.0) 5.7 (5.5-6.0) .76
Hematocrit, % 29 (27-30) 28 (27-29) 1.00
Glucose, mmol/L 7.7 (6.3-9.2) 7.0 (5.7-7.9) .44
Sodium, mmol/L 137 (136-138) 137 (135-138) .31
Potassium, mmol/L 4.0 (3.7-4.3) 4.0 (3.9-4.2) .34
Chloride, mmol/L 108 (107-110) 108 (107-109) .11
Lactate, mmol/L 1.6 (1.2-1.9) 1.5 (1.0-2.2) .55
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ﬂuid balance during the days before the study and showed signs of
tissue edema. The fact that ultraﬁltrationwas not associated with ﬂow
changes at the capillary level may indicate that extravascular ﬂuids
were recruited to the vascular system, thereby preventing hypovo-
lemia. The reduced heart rate and the increased P/F ratio, as markers
of pulmonary edema, and the absence of change in hematocrit are
consistent with this view. An alternative reason for the absence of
microcirculatory ﬂow alterations during ultraﬁltration in our study
might be hidden in the dosage and in the timing of the amount of
ultraﬁltrate. It seems plausible that, when the targeted ﬂuid balance is
more negative, the microvascular ﬂow alterations become present. In
the earlier stage of shock, a net ﬂuid exchange from the interstitium to
the intravascular space may be more difﬁcult because of endothelial
dysfunction. In this case, a negative ﬂuid balance will presumably
result in intravascular hypovolaemia.
The amount and timeline of the ultraﬁltration are within the
generally accepted ICU practice. However, it is conceivable that an
earlier start of ultraﬁltration or a more rigorous amount may be
possible without compromising organ perfusion. Strict control of ﬂuid
balance seems important because a positive ﬂuid balance is associated
with an increased mortality and incidence of AKI [10,22]. Future
studies are needed to determine the optimal timing and dosing of
ultraﬁltration in acutely ill patients with RRT. Direct in vivo
observation of the microcirculation may be a valuable tool for
assessing organ perfusion at the bedside during such intervention.
We acknowledge several limitations of the study. In this pilot
study, the number of patients is limited. Therefore, we cannot exclude
smaller changes than 0.4 AU in microvascular blood ﬂow during
ultraﬁltration, according to the power calculation. Second, the range
in the amount of ultraﬁltration is limited; and the changes in capillary
ﬂow may occur outside the scope of this range. Third, themicrovascular ﬂow alterations are conceivably present in other
vascular beds than in the observed sublingual area [15,23]. The data
on the abdominal pressure were not recorded.
5. Conclusions
The target reduction of substitution ﬂow with CVVH was not
associated with a change in microcirculatory blood ﬂow during
negative ﬂuid balance ultraﬁltration in stabilized ICU patients.
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